Entering text into the input field will update the search result below

CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q4 2021 Results - Earnings Call Transcript

Mar. 01, 2022 11:38 PM ETCytomX Therapeutics, Inc. (CTMX)
SA Transcripts profile picture
SA Transcripts

Call Start: 17:00 January 1, 0000 5:43 PM ET

CytomX Therapeutics, Inc. (NASDAQ:CTMX)

Q4 2021 Earnings Conference Call

March 1, 2022 17:00 ET

Company Participants

Chau Cheng - Vice President of Investor Relations & Corporate Communications

Sean McCarthy - Chairman & Chief Executive Officer

Amy Peterson - President & Chief Operating Officer

Chris Ogden - Interim Principal Accounting Officer and Vice President of Finance & Accounting

Conference Call Participants

Gavin Scott - JPMorgan

Kaveri Pohlman - BTIG

Joe Catanzaro - Piper Stanley

Roger Song - Jefferies

Mitchell Kapoor - H.C. Wainwright

Peter Lawson - Barclays


Good afternoon everyone. Thank you for standing by. Welcome to the CytomX Therapeutics Fourth Quarter and Full Year 2021 Financial Results Call. Please be advised that today's call is being recorded.

I would now like to hand the call over to your host today, Chau Cheng, CytomX's Vice President, Investor Relations and Corporate Communications. Please go ahead.

Chau Cheng

Thank you, Michelle. Good afternoon and thank you for joining us. With me today are Dr. Sean McCarthy, CytomX' Chief Executive Officer and Chairman; Dr. Amy Peterson, President and Chief Operating Officer; and Chris Ogden, Vice President, Finance and Accounting.

Earlier today, we issued a press release that includes a summary of our fourth quarter and full year 2021 financial results and highlights the important progress we made during the year. We encourage everyone to read today's press release and the associated materials which have been filed with the SEC. Additionally, the press release and recording of this call can be found under the Investors and News section of our website at cytomx.com. Please note that during today's call, we will be making forward-looking statements. Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks, including the uncertainty surrounding the COVID pandemic that are difficult to predict and many

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.